|1.||Lee, Hyeung-Sik: 2 articles (08/2010 - 12/2008)|
|2.||Kim, Jong-Dae: 2 articles (08/2010 - 12/2008)|
|3.||Park, Mee-Yeon: 2 articles (08/2010 - 12/2008)|
|4.||Choi, Hae-Yun: 2 articles (08/2010 - 12/2008)|
|5.||Ku, Sae-Kwang: 2 articles (08/2010 - 12/2008)|
|6.||Toledo, Fernando: 1 article (03/2012)|
|7.||Namiesnik, Jacek: 1 article (03/2012)|
|8.||Leontowicz, Hanna: 1 article (03/2012)|
|9.||Trakhtenberg, Simon: 1 article (03/2012)|
|10.||Leontowicz, Maria: 1 article (03/2012)|
|1.||Coronary Artery Disease (Coronary Atherosclerosis)
03/01/1999 - "Multiglycosidorum tripterygii, a new immunosuppressant, supresses coronary arteriosclerosis after heart transplantation."
06/15/1998 - "Inhibitory effect of Multiglycosidorum tripterygii on coronary arteriosclerosis after heart transplantation."
03/01/1999 - "In this study, we investigate the effect of multiglycosidorum tripterygii on graft coronary arteriosclerosis and platelet-derived growth factor A mRNA expression of transplanted hearts. "
03/01/1999 - "Multiglycosidorum tripterygii is superior to cyclosporine in prevention and attenuation of graft coronary arteriosclerosis and this efficacy is probably associated with the depressed expression of graft platelet-derived growth factor A mRNA in the multiglycosidorum tripterygii-treated groups."
|2.||Asthma (Bronchial Asthma)
08/01/2010 - "As part of a safety evaluation of MT extract for use in asthma, the 28 day repeat oral dose toxicity of an aqueous MT extract was evaluated at 800, 400 and 200mg/kg per day dose levels. "
12/01/2008 - "As part of a safety evaluation of MT extracts for use in asthma, the potential genotoxicity of an aqueous MT extract was evaluated using the standard battery of tests (bacterial reverse mutation assay; chromosomal aberrations assay; mouse micronucleus assay) recommended by Korea Food and Drug Administration (KFDA). "
|3.||Idiopathic Thrombocytopenic Purpura (Thrombocytopenic Purpura, Autoimmune)
02/01/2004 - "[Treatment of chronic refractory idiopathic thrombocytopenic purpura in children with multiglycosidorum Tripterygii and prednisone]."
02/01/2004 - "In order to determine the curative effect of multiglycosidorum Tripterygii and prednisone for treatment of children with chronic refractory idiopathic thrombocytopenic purpura (ITP), a total of 28 patients had been treated with multiglycosidorum Tripterygii and prednisone. "
|4.||Liver Diseases (Liver Disease)
|1.||Messenger RNA (mRNA)
|2.||platelet-derived growth factor A
|6.||Inosine Triphosphate (ITP)
|2.||Heart Transplantation (Grafting, Heart)